Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 144

Artivion, Inc.

AORTNYSEEQUITYCurrent

SEC Filing

Filed Sep 10, 2026Accepted Sep 10, 2026, 11:43 AM EDTCIK 784199Accession 0001959173-26-006850
Share

Company context

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with aortic diseases. Artivion’s four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www. Artivion.com.

Current securities

Recent company filings

  1. 144 filingSep 3, 2026
  2. 144 filingSep 2, 2026
  3. 144 filingAug 27, 2026
  4. 144 filingAug 19, 2026
  5. 144 filingAug 14, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗